z-logo
open-access-imgOpen Access
Therapeutic options in refractory anti-MDA5 dermatomyositis triggered by SARS-CoV-2 infection
Author(s) -
Elena Jugănaru,
Alexandra O. Constantinescu,
Claudia-Oana Cobilinschi,
Cosmin Constantinescu
Publication year - 2022
Publication title -
romanian journal of rheumatology
Language(s) - English
Resource type - Journals
eISSN - 2069-6086
pISSN - 1843-0791
DOI - 10.37897/rjr.2022.3.6
Subject(s) - medicine , hydroxychloroquine , dermatomyositis , rituximab , dermatology , interstitial lung disease , tacrolimus , rheumatoid arthritis , disease , antisynthetase syndrome , autoimmunity , immunology , lung , covid-19 , lymphoma , infectious disease (medical specialty) , transplantation

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom